Format

Send to

Choose Destination
Nat Genet. 2013 Mar;45(3):234-8. doi: 10.1038/ng.2555.

Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease.

Author information

1
The University of Queensland, Queensland Brain Institute, Brisbane, Queensland, Australia. j.gratten1@uq.edu.au

Abstract

Pedigree, linkage and association studies are consistent with heritable variation for complex disease due to the segregation of genetic factors in families and in the population. In contrast, de novo mutations make only minor contributions to heritability estimates for complex traits. Nonetheless, some de novo variants are known to be important in disease etiology. The identification of risk-conferring de novo variants will contribute to the discovery of etiologically relevant genes and pathways and may help in genetic counseling. There is considerable interest in the role of such mutations in complex neuropsychiatric disease, largely driven by new genotyping and sequencing technologies. An important role for large de novo copy number variations has been established. Recently, whole-exome sequencing has been used to extend the investigation of de novo variation to point mutations in protein-coding regions. Here, we consider several challenges for the interpretation of such mutations in the context of their role in neuropsychiatric disease.

PMID:
23438595
DOI:
10.1038/ng.2555
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center